Citigroup’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-783
| Closed | -$3K | – | 5285 |
|
|
2019
Q3 | $3K | Sell |
783
-363
| -32% | -$1.39K | ﹤0.01% | 4929 |
|
|
2019
Q2 | $8K | Sell |
1,146
-1,082
| -49% | -$7.55K | ﹤0.01% | 4808 |
|
|
2019
Q1 | $8K | Sell |
2,228
-38
| -2% | -$136 | ﹤0.01% | 4809 |
|
|
2018
Q4 | $9K | Sell |
2,266
-56
| -2% | -$222 | ﹤0.01% | 4670 |
|
|
2018
Q3 | $46K | Buy |
+2,322
| New | +$46K | ﹤0.01% | 4134 |
|
|
2018
Q2 | – | Sell |
-1,017
| Closed | -$38K | – | 5161 |
|
|
2018
Q1 | $38K | Buy |
1,017
+589
| +138% | +$22K | ﹤0.01% | 3925 |
|
|
2017
Q4 | $33K | Buy |
+428
| New | +$33K | ﹤0.01% | 4018 |
|